3 ms·
I don't think this is comparable. The needle must reach the retina. I am no expert but I recall the phase one trials were done to merely test if the vector was
by DubiousPusher 6y ago
I don't think this is comparable. The needle must reach the retina. I am no expert but I recall the phase one trials were done to merely test if the vector was safe.
- refurb 6y agoMacular degeneration is very common with 11M people in the US affected. It’s treated with intraoccular injections of VEGF inhibitors.